ADHD: prevalence and effect on opioid use disorder treatment outcome in a French sample of patients receiving medication for opioid use disorder—the influence of impulsivity as a mediating factor

Autor: Auxane Beslot, Marie Grall-Bronnec, Marianne Balem, Benoit Schreck, Edouard-Jules Laforgue, Caroline Victorri-Vigneau, Morgane Guillou-Landreat, Juliette Leboucher, OPAL-Group, Gaëlle Challet-Bouju, Clémence Cabelguen

Publikováno v: Harm Reduction Journal, Vol 21, Iss 1, Pp 1-13 (2024)

Abstract Background Opioid use disorder (OUD) poses a global health challenge, and despite medications for opioid use disorder (MOUD) and psychosocial interventions, relapse remains a significant concern. Comorbid psychiatric disorders, including att

Externí odkaz: https://doaj.org/article/dcd20e11567c46a1aa7f60e240037e3e

Effect of early intervention for early-stage psychotic disorders on suicidal behaviours – a systematic review protocol

Autor: Elkhan Tahmazov, Athéna Blachier, Patrice Nabbe, Morgane Guillou-Landreat, Michel Walter, Christophe Lemey

Publikováno v: Frontiers in Psychiatry, Vol 15 (2024)

BackgroundThe early stages of psychotic disorders correspond to the early phases of the disease and include the prodromal phase and first-episode psychosis; they constitute a period at high risk of suicidal behaviour. A long duration of untreated psy

Externí odkaz: https://doaj.org/article/f137a196dfe946e5906c3b0ccf3a7c32

How do people who use drugs receiving Opioid Medication Therapy perceive their treatment ? A multicentre study

Autor: Morgane Guillou Landreat, Antoine Dany, Gaelle Challet Bouju, Edouard-Jules Laforgue, J. Cholet, Juliette Leboucher, Jean Benoit Hardouin, the OPAL Group, Caroline Victorri Vigneau, Marie Grall Bronnec

Publikováno v: Harm Reduction Journal, Vol 19, Iss 1, Pp 1-12 (2022)

Abstract Background The resurgence of heroin use and the misuse of pharmaceutical opioids are some of the reasons for a worldwide increase in opioid dependence. Opioid Medication Therapies (OMT) have amply demonstrated their efficacy. From a medical

Externí odkaz: https://doaj.org/article/87621953962d43f7afe03c2f98492d6f

Innovative cardiovascular primary prevention population-based strategies: a 2-year hybrid type 1 implementation randomised control trial (RCT) which evaluates behavioural change conducted by community champions compared with brief advice only from the SPICES project (scaling-up packages of interventions for cardiovascular disease prevention in selected sites in Europe and sub-Saharan Africa)

Autor: Delphine Le Goff, Marie Barais, Gabriel Perraud, Jeremy Derriennic, Paul Aujoulat, Morgane Guillou-Landreat, Jean Yves Le Reste

Publikováno v: BMC Public Health, Vol 21, Iss 1, Pp 1-9 (2021)

Abstract Background Cardiovascular diseases (CVD) caused 17.9 million deaths worldwide in 2016, being the world’s leading cause of death. Prevention of CVD in high-income countries is expensive and fails to reach the population at risk. In low-inco

Externí odkaz: https://doaj.org/article/0fd9971eb5454491bbfb1c7a69b921dd

How do people who use drugs receiving Opioid Medication Therapy perceive their treatment ? A multicentre study.

Autor: Guillou Landreat, Morgane^1,2 (AUTHOR), Dany, Antoine² (AUTHOR), Challet Bouju, Gaelle^1,3 (AUTHOR), Laforgue, Edouard-Jules^1,3,4 (AUTHOR), Cholet, J.³ (AUTHOR), Leboucher, Juliette³ (AUTHOR), Hardouin, Jean Benoit¹ (AUTHOR), the OPAL Group (AUTHOR), Bodenez, Pierre (AUTHOR), Grall-Bronnec, Marie (AUTHOR), Guillou-Landreat, Morgane (AUTHOR), Le Geay, Bertrand (AUTHOR), Martineau, Isabelle (AUTHOR), Levassor, Philippe (AUTHOR), Bolo, Paul (AUTHOR), Guillet, Jean-Yves (AUTHOR), Guillery, Xavier (AUTHOR), Dano, Corine (AUTHOR), Victorri Vigneau, Caroline^1,4 (AUTHOR), Grall Bronnec, Marie^1,2,3,5 (AUTHOR) marie.bronnec@chu-nantes.fr

Publikováno v: Harm Reduction Journal. 3/28/2022, Vol. 19 Issue 1, p1-12. 12p.